There are 2789 resources available
170P - Identification and validation of novel immune genomic subtypes for triple-positive breast cancer
Presenter: Jian Zheng
Session: ePoster Display
171P - Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy
Presenter: Shu Yazaki
Session: ePoster Display
130P - Deep learning magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage invasive breast cancer
Presenter: Zifan He
Session: ePoster Display
131P - Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer
Presenter: Maria Alice Franzoi
Session: ePoster Display
132P - Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial
Presenter: Katya Galactionova
Session: ePoster Display
133P - Magnetic resonance imaging radiomics predicts high and low recurrence risk and is associated with LncRNAs in early-stage invasive breast cancer
Presenter: Wei Ren
Session: ePoster Display
134P - Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC)
Presenter: Daniele Presti
Session: ePoster Display
135P - Hot flashes during adjuvant hormone therapy predict treatment discontinuation and outcome among breast cancer patients
Presenter: Erwei Zeng
Session: ePoster Display
183P - Clinical treatment score post-5 years (CTS5) as a tool for risk estimation of late recurrence in Thai patients with estrogen receptor positive, early breast cancer: A validation study
Presenter: Panchanin Patanayindee
Session: ePoster Display